Startseite
Investieren
Aktien
USA
NASDAQ
Catabasis Pharmaceuticals Inc (CATB) Börsenkurse

Catabasis Pharmaceuticals Inc (CATB)

8,54

0,00

(0,00%)

Geschlossen 20 Juli 10:00PM

0,00

(0,00%)

Nach Börsenschluss: -

Catabasis Pharmaceuticals Inc (CATB) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

8,54

( - )

Gebot

8,45

Fragen

8,63

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

481,946M

Handelsende

8,54

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

56.434.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-5,11

Gewinn pro Aktie (EPS)

-1,67

Erlöse

Nettogewinn

-94,26M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.astriatx.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus

-- Astria Reflects Company’s Patient-Focused Mission -- -- Promising Lead Program STAR-0215 is in Preclinical Development to Prevent Attacks in...

Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for the second quarter ended June...

Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer...

Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer...

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer...

Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update

-- QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma Kallikrein, Progresses in Preclinical Development for the...

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

-- Recently Completed Acquisition of Quellis Biosciences Includes QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma...

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer...

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.

Acquisition Includes QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma Kallikrein in Preclinical Development for the...

Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

-- Cash and Cash Equivalents Totaled $52.9 Million as of September 30, 2020 -- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CATB - Frequently Asked Questions (FAQ)

What is the current Catabasis Pharmaceuticals share price?

The current share price of Catabasis Pharmaceuticals is US$ 8,54

How many Catabasis Pharmaceuticals shares are in issue?

Catabasis Pharmaceuticals has 56.434.000 shares in issue

What is the market cap of Catabasis Pharmaceuticals?

The market capitalisation of Catabasis Pharmaceuticals is USD 481,95M

What is the 1 year trading range for Catabasis Pharmaceuticals share price?

Catabasis Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Catabasis Pharmaceuticals?

The price to earnings ratio of Catabasis Pharmaceuticals is -5,11

What is the reporting currency for Catabasis Pharmaceuticals?

Catabasis Pharmaceuticals reports financial results in USD

What is the latest annual profit for Catabasis Pharmaceuticals?

The latest annual profit of Catabasis Pharmaceuticals is USD -94,26M

What is the registered address of Catabasis Pharmaceuticals?

The registered address for Catabasis Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Catabasis Pharmaceuticals website address?

The website address for Catabasis Pharmaceuticals is www.astriatx.com

Which industry sector does Catabasis Pharmaceuticals operate in?

Catabasis Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
NEXMNexMetals Mining Corporation	US$ 6,50 (173,11%)	103,24k
TELOTelomir Pharmaceuticals Inc	US$ 2,295 (89,67%)	135,81M
IXHLIncannex Healthcare Ltd	US$ 0,6001 (62,15%)	491,07M
CYCCCyclacel Pharmaceuticals Inc	US$ 13,07 (58,81%)	22,37M
BZAIBlaize Holdings Inc	US$ 4,80 (58,42%)	73,13M
PTNMPitanium Ltd	US$ 2,18 (-67,02%)	4,6M
YHCLQR House Inc	US$ 2,38 (-63,77%)	9,87M
BCLIBrainstorm Cell Therapeutics Inc	US$ 0,72 (-38,46%)	26,73k
SRPTSarepta Therapeutics Inc New	US$ 14,07 (-35,96%)	78,12M
CLSDClearside Biomedical Inc	US$ 0,4076 (-32,27%)	3,65M
OPENOpendoor Technologies Inc	US$ 2,25 (36,36%)	587,3M
IXHLIncannex Healthcare Ltd	US$ 0,6001 (62,15%)	491,07M
BTOGBit Origin Ltd	US$ 0,7675 (21,63%)	361,05M
LCIDLucid Group Inc	US$ 3,035 (-2,72%)	292,41M
NVDANVIDIA Corporation	US$ 172,41 (-0,34%)	144,72M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

NASDAQ

CATB

Catabasis Pharmaceuticals

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Catabasis Pharmaceuticals Inc (CATB)

Catabasis Pharmaceuticals Inc (CATB) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Catabasis Pharmaceuticals Inc

CATB Neueste Nachrichten

Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus

Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference

Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.

Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

CATB - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Catabasis Pharmaceuticals Inc (CATB)

Catabasis Pharmaceuticals Inc (CATB) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Catabasis Pharmaceuticals Inc

CATB Neueste Nachrichten

Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus

Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference

Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.

Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

CATB - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS